Licensing opportunity from NIH: calcium channel modifiers with application in HIV and AIDS Oct. 8, 1999
Promising anti-HIV drug candidate strongly inhibits T-tropic and T/M-tropic infections in SCID mice Oct. 4, 1999
Soluble Tat peptide analogues, HIV replication inhibitors, available for licensing from NIH Oct. 4, 1999